Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide and a leading cause of death worldwide. Its incidence continues to increase in the US due to hepatitis C infection and nonalcoholic steatohepatitis. Liver transplantation and resection remain the best therapeutic op...

Full description

Saved in:
Bibliographic Details
Published in:Gene Expr
Main Authors: Onuma, Amblessed E., Zhang, Hongji, Huang, Hai, Williams, Terence M., Noonan, Anne, Tsung, Allan
Format: Artigo
Language:Inglês
Published: Cognizant Communication Corporation 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284108/
https://ncbi.nlm.nih.gov/pubmed/32340652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/105221620X15880179864121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items